Cargando…
Efficacy and safety of dorzagliatin for type 2 diabetes mellitus: A meta-analysis and trial sequential analysis
OBJECTIVE: To evaluate the efficacy and safety of dorzagliatin in the treatment of type 2 diabetes mellitus (T2DM) by using meta-analysis and trial sequential analysis (TSA). METHOD: Search for clinical trials of dorzagliatin for T2DM in eight databases, with a time limit of build to July 2022. The...
Autores principales: | Yu, Yunfeng, Yang, Xingyu, Tong, Keke, Yin, Shuang, Hu, Gang, Zhang, Fei, Jiang, Pengfei, Zhou, Manli, Jian, Weixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727304/ https://www.ncbi.nlm.nih.gov/pubmed/36505359 http://dx.doi.org/10.3389/fcvm.2022.1041044 |
Ejemplares similares
-
Optimal dose of tirzepatide for type 2 diabetes mellitus: A meta-analysis and trial sequential analysis
por: Yu, Yunfeng, et al.
Publicado: (2022) -
Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis
por: Yu, Yunfeng, et al.
Publicado: (2022) -
Gastrointestinal adverse events of tirzepatide in the treatment of type 2 diabetes mellitus: A meta-analysis and trials sequential analysis
por: Tong, Keke, et al.
Publicado: (2023) -
Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus
por: Wang, Kun, et al.
Publicado: (2023) -
Effect of renal impairment on the pharmacokinetics and safety of dorzagliatin, a novel dual‐acting glucokinase activator
por: Miao, Jia, et al.
Publicado: (2021)